TY - CHAP
T1 - Developing Treatments for Alzheimer’s and Related Disorders with Precision Medicine
T2 - A Vision
AU - Avramopoulos, Dimitrios
AU - Kapogiannis, Dimitrios
AU - Leoutsakos, Jeannie Marie
AU - Lyketsos, Constantine G.
AU - Mahairaki, Vasiliki
AU - Nowrangi, Milap
AU - Oishi, Kenichi
AU - Oh, Esther S.
AU - Rosenberg, Paul B.
AU - Samus, Quincy
AU - Smith, Gwenn S.
AU - Witwer, Kenneth
AU - Yasar, Sevil
AU - Zandi, Peter P.
N1 - Funding Information:
Acknowledgments We are grateful to the many supporters of the Richman Center and to Jiaxin Li for the development of Fig. 5. Dr. Kapogiannis’ effort is supported in part by the Intramural Research Program, National Institute on Aging (NIA/NIH).
Publisher Copyright:
© 2021, The Author(s), under exclusive license to Springer Nature Switzerland AG.
PY - 2021
Y1 - 2021
N2 - Precision medicine, also known as personalized medicine, is concerned with finding the right treatment for the right patient at the right time. It is a way of thinking focused on parsing heterogeneity ultimately down to the level of the individual. Its main mission is to identify characteristics of heterogeneous clinical conditions so as to target tailored therapies to individuals. Precision Medicine however is not an agnostic collection of all manner of clinical, genetic and other biologic data in select cohorts. This is an important point. Simply collecting as much information as possible on individuals without applying this way of thinking should not be considered Precision Medicine.
AB - Precision medicine, also known as personalized medicine, is concerned with finding the right treatment for the right patient at the right time. It is a way of thinking focused on parsing heterogeneity ultimately down to the level of the individual. Its main mission is to identify characteristics of heterogeneous clinical conditions so as to target tailored therapies to individuals. Precision Medicine however is not an agnostic collection of all manner of clinical, genetic and other biologic data in select cohorts. This is an important point. Simply collecting as much information as possible on individuals without applying this way of thinking should not be considered Precision Medicine.
KW - Alzheimer’s
KW - Precision medicine treatments
UR - http://www.scopus.com/inward/record.url?scp=85123600122&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85123600122&partnerID=8YFLogxK
U2 - 10.1007/978-3-030-78787-5_49
DO - 10.1007/978-3-030-78787-5_49
M3 - Chapter
C2 - 35023131
AN - SCOPUS:85123600122
T3 - Advances in Experimental Medicine and Biology
SP - 395
EP - 402
BT - Advances in Experimental Medicine and Biology
PB - Springer
ER -